Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0043 | 0.6693 | 0.6693 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.1064 | 0.1064 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0035 | 0.5039 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.4503 | 0.4503 |
Onchocerca volvulus | 0.001 | 0 | 0.5 | |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0047 | 0.7465 | 0.7465 |
Loa Loa (eye worm) | TAR-binding protein | 0.006 | 1 | 1 |
Brugia malayi | Inositol-1 | 0.0035 | 0.5039 | 0.5039 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.4503 | 0.4503 |
Schistosoma mansoni | tar DNA-binding protein | 0.006 | 1 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0015 | 0.1064 | 0.1064 |
Brugia malayi | RNA recognition motif domain containing protein | 0.006 | 1 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.006 | 1 | 1 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.001 | 0 | 0.5 |
Entamoeba histolytica | myo-inositol monophosphatase, putative | 0.0035 | 0.5039 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0043 | 0.6693 | 0.6693 |
Echinococcus multilocularis | GPCR, family 2 | 0.0015 | 0.1064 | 0.1064 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0043 | 0.6693 | 0.6693 |
Schistosoma mansoni | tar DNA-binding protein | 0.006 | 1 | 1 |
Trypanosoma brucei | inositol-1(or 4)-monophosphatase 1, putative | 0.0035 | 0.5039 | 0.5 |
Leishmania major | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0035 | 0.5039 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.006 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.1064 | 0.1064 |
Trichomonas vaginalis | inositol monophosphatase, putative | 0.0035 | 0.5039 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0047 | 0.7465 | 0.7465 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0035 | 0.5039 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0043 | 0.6693 | 0.6693 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0035 | 0.5039 | 0.5 |
Brugia malayi | TAR-binding protein | 0.006 | 1 | 1 |
Toxoplasma gondii | inositol(myo)-1(or 4)-monophosphatase 2, putative | 0.0035 | 0.5039 | 0.5 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0015 | 0.1064 | 0.1064 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0015 | 0.1064 | 0.1064 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0043 | 0.6693 | 0.6693 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0032 | 0.4503 | 0.4503 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0043 | 0.6693 | 0.6693 |
Echinococcus granulosus | tar DNA binding protein | 0.006 | 1 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0015 | 0.1064 | 0.1064 |
Mycobacterium leprae | possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). | 0.0031 | 0.4312 | 0.5 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0015 | 0.1064 | 0.1064 |
Onchocerca volvulus | Bile acid receptor homolog | 0.001 | 0 | 0.5 |
Loa Loa (eye worm) | inositol-1 | 0.0035 | 0.5039 | 0.5039 |
Schistosoma mansoni | inositol monophosphatase | 0.0035 | 0.5039 | 0.5039 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.006 | 1 | 1 |
Mycobacterium ulcerans | extragenic suppressor protein SuhB | 0.0035 | 0.5039 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0043 | 0.6693 | 0.6693 |
Schistosoma mansoni | inositol monophosphatase | 0.0035 | 0.5039 | 0.5039 |
Echinococcus multilocularis | tar DNA binding protein | 0.006 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.1064 | 0.1064 |
Schistosoma mansoni | tar DNA-binding protein | 0.006 | 1 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0043 | 0.6693 | 0.6693 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0035 | 0.5039 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.7465 | 0.7465 |
Echinococcus granulosus | inositol monophosphatase 1 | 0.0035 | 0.5039 | 0.5039 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.1064 | 0.1064 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0015 | 0.1064 | 0.1064 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0015 | 0.1064 | 0.1064 |
Mycobacterium tuberculosis | Inositol-1-monophosphatase SuhB | 0.0031 | 0.4312 | 0.5 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.001 | 0 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0043 | 0.6693 | 0.6693 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0047 | 0.7465 | 0.7465 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.1064 | 0.1064 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0035 | 0.5039 | 0.5 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0015 | 0.1064 | 0.1064 |
Echinococcus multilocularis | inositol monophosphatase 1 | 0.0035 | 0.5039 | 0.5039 |
Schistosoma mansoni | tar DNA-binding protein | 0.006 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | Antifungal activity against Candida albicans by standard broth dilution technique | ChEMBL. | 114657 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.